HCC CONNECT has summarised the highlights from ESMO 2018 for you
Hepatocellular carcinoma by Dr. Changhoon Yoo, Asan Medical Center, University of Ulsan College of Medicine, Korea
Dr Changhoon Yoo is a medical oncologist who specialises in the care of patients with gastrointestinal cancers including hepatocellular carcinoma. He is an Assistant Professor at Asan Medical Center in Seoul, South Korea. Dr Yoo obtained his medical degree at the University of Ulsan College of Medicine, Seoul, South Korea and completed post graduate training at Asan Medical Center. He has participated in multiple clinical trials and translational research for the development of novel agents for patients with hepatocellular carcinoma. His research initiatives include the integration of novel targeted and immune-based therapy into the treatment of hepatocellular carcinoma. Relevant publications Kim HD, Song GW, Park S, Jung MK, Kim MH, Kang HJ, Yoo C, Yi K, Kim KH, Eo S, Moon DB, Hong SM, Ju YS, Shin EC, Hwang S, Park SH. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma. Gastroenterology 2018 Aug 23; pii: S0016-5085(18)34897-2. doi: 10.1053/j.gastro.2018.08.030. [Epub ahead of print] PMID: 30145359 Yoo C, Kang J, Lim HY, Kim JH, Lee MA, Lee KH, Kim TY, Ryoo BY. Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma. Cancer Res Treat 2018 Jun 13. doi: 10.4143/crt.2018.226. [Epub ahead of print] PMID: 29898591 Chae H, Cho H, Yoo C, Kim KP, Jeong JH, Chang HM, Kang J, Lee HC, Lim YS, Kim KM, Shim JH, Lee SS, Park DH, Song TJ, Hwang S, Song GW, Moon DB, Lee YJ, Lee JH, Ryoo BY. Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin. Int J Biol Markers 2018 Jun 1:1724600818777239. doi: 10.1177/1724600818777239. [Epub ahead of print] PMID: 29874985 Cho H, Yoo C, Kim KP, Jeong JH, Kang J, Chang HM, Lee SS, Park DH, Song TJ, Lee SK, Kim MH, Lee HC, Lim YS, Kim KM, Shim JH, Hwang S, Song GW, Moon DB, Lee JH, Lee YJ, Ryoo BY. Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin. Invest New Drugs 2018 Jun;36(3):496-502. doi: 10.1007/s10637-017-0548-7. Epub 2017 Dec 1. PMID: 29192354 Yoo C, Kang J, Kim D, Kim KP, Ryoo BY, Hong SM, Hwang JJ, Jeong SY, Hwang S, Kim KH, Lee YJ, Hoeflich KP, Schmidt-Kittler O, Miller S, Choi EK. Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma. Oncotarget 2017 Jun 13;8(24):38592-38601. doi: 10.18632/oncotarget.16951.
Asst. Prof. Changhoon Yoo has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Bayer, Eisai, MSD, Ono and Ipsen.
HCC CONNECT Update from ESMO 2019
HCC CONNECT has summarised highlights of the recent ESMO 2019 meeting for you
Experts
Dr Su Pin Choo-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Downloadable 
5 MIN
Sep 2021 
HCC CONNECT Update from ILCA and ESMO 2020
HCC CONNECT has summarised the highlights from ILCA and ESMO 2020 for you.Liver Cancer update by Dr. Su Pin Choo, Curie Oncology and National Cancer Centre, Singapore
Experts
Dr Su Pin Choo-
Downloadable
Resouces -
5 MIN
-
Sep 2021
Download the slides 
Programme summary
Duration 5 MIN- Downloadable resources Yes
-
Download the slides
-
Language(s)
Duration 
Language(s)
Share this programme
Brought to you by
HCC CONNECT is an initiative of COR2ED, supported by Independent Medical Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.
Meet the expertsOther programmes of interest
Other
Oncology
The evolving role of liquid biopsy in biomarker testing
Clinical application of liquid biopsy, and how it applies to NSCLC, breast and colorectal cancer
Experts
Assoc. Prof. Umberto Malapelle-
Downloadable
Resources -
5 MIN
-
Jul 2024
Interactive patient case
Oncology
Advanced renal cell carcinoma: Managing a long-term durable response
Maximising outcomes for patients with advanced RCC
Experts
Prof. Michael StaehlerEndorsed by
-
15 MIN
-
Jun 2024
Other
Episode
1
of 1
Oncology
Overcoming pre-analytical phase challenges in gastric, prostate and lung cancer
Medical experts make recommendations for best practice
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
5 MIN
-
Jun 2024
Conference update
Oncology
Oncogene-addicted NSCLC: Highlights from ASCO 2024
The latest non-small cell lung cancer data presented at ASCO
Experts
Prof. Nicolas Girard-
Downloadable
Resources -
3 MIN
-
Jun 2024
Conference update
Oncology
Upper and lower GI cancer update from ASCO 2024
GI oncologists review the latest data presented at ASCO 2024
Experts
Dr Samuel J Klempner, Dr Elizabeth Smyth, Prof. Jenny Seligmann, Dr Dominik Modest-
8 MIN
-
Jun 2024
Oncology Hemato-oncology
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)
Medical experts discuss the latest learnings from clinical practice
Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Joshua Richter-
Downloadable
Resources -
76 MIN
-
Jun 2024
